Tech Mahindra & Reagene Biosciences file for Corona attacking molecule patent
There is good news about fight against coronavirus. IT company Tech Mahindra together with ReaGene Biosciences has found a new molecule. There is a possibility that this may kill the coronavirus. Now it is ready to be patented, so that further research can be done on it.
Name is not disclosed until the patent
Nikhil Malhotra, Global Head (Makers Lab) of Tech Mahindra, says the name of the molecule cannot be disclosed until it is patented. Tech Mahindra and ReaGene are in the process of research. Makers Lab Tech is the research and development arm of Mahindra.
Research done on 8,000 molecules
According to Malhotra, Makers Lab undertook a computational modeling analysis of coronaviruses. Based on this computational docking and modeling studies, Tech Mahindra and the partner company shortlisted 10 molecules out of 8,000 FDA-approved molecules. These 10 molecules were filtered through technology. These were tested in Bengaluru. After this their number was brought to 3.
Test done on 3D lung
After this, the company prepared a 3D lung and tested it. Testing showed that a molecule is functioning according to research. Malhotra said that after this we completed computational analysis and our partner completed clinical analysis.
He said that ‘it needs further study on animals, but we are confident that this technique will reduce the discovery mechanism in biological computation. We are studying more to check its efficacy.’ Malhotra said that trials are underway on many medicines all over the world. Right now, people rely only on the vaccine to stay safe from the deadly coronavirus.
